Neurocrine Clinical Site

Stockholm 17176

1 studies enrolling now · 3 studies all time

What they study most

Congenital Adrenal Hyperplasia, Major Depressive Disorder

Studies at this site

• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia — Running, not enrolling
• Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD) — Completed